These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 25837457)

  • 1. [Risk of sudden death according to the latest European guidelines on hypertrophic cardiomyopathy].
    Iacovoni A; Quarta G; Senni M
    G Ital Cardiol (Rome); 2015 Mar; 16(3):143-6. PubMed ID: 25837457
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluating and Reducing the Risk of Sudden Death in Hypertrophic Cardiomyopathy.
    Udelson JE
    Circulation; 2019 Feb; 139(6):727-729. PubMed ID: 30715941
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevention of sudden cardiac death in hypertrophic cardiomyopathy.
    O'Mahony C; Elliott PM
    Heart; 2014 Feb; 100(3):254-60. PubMed ID: 23574968
    [No Abstract]   [Full Text] [Related]  

  • 4. The athlete's heart: prevention of sudden cardiac death.
    Manshadi R
    Rev Cardiovasc Med; 2008; 9(4):259-60. PubMed ID: 19122583
    [No Abstract]   [Full Text] [Related]  

  • 5. Hypertrophic cardiomyopathy: ask athletes these 9 questions.
    deWeber K; Beutler A
    J Fam Pract; 2009 Nov; 58(11):576-84. PubMed ID: 19891935
    [No Abstract]   [Full Text] [Related]  

  • 6. Risk assessment in hypertrophic cardiomyopathy.
    Saumarez RC
    Heart; 2009 Mar; 95(5):421; author reply 421. PubMed ID: 19218265
    [No Abstract]   [Full Text] [Related]  

  • 7. Noninvasive risk stratification prevents sudden death due to paroxysmal atrial fibrillation in hypertrophic cardiomyopathy.
    Limongelli G; Elliott PM; Pacileo G; Sarubbi B; Thaman R; Calabrò P; Vergara P; Iacomino M; Russo MG; Calabrò R
    J Cardiovasc Med (Hagerstown); 2006 Sep; 7(9):711-3. PubMed ID: 16932087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypertrophic cardiomyopathy and sudden death: new perspectives on risk stratification and prevention with the implantable cardioverter-defibrillator.
    Maron BJ
    Eur Heart J; 2000 Dec; 21(24):1979-83. PubMed ID: 11102243
    [No Abstract]   [Full Text] [Related]  

  • 9. A validation study of the 2003 American College of Cardiology/European Society of Cardiology and 2011 American College of Cardiology Foundation/American Heart Association risk stratification and treatment algorithms for sudden cardiac death in patients with hypertrophic cardiomyopathy.
    O'Mahony C; Tome-Esteban M; Lambiase PD; Pantazis A; Dickie S; McKenna WJ; Elliott PM
    Heart; 2013 Apr; 99(8):534-41. PubMed ID: 23339826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sudden cardiac arrest in a young patient with hypertrophic cardiomyopathy and zero canonical risk factors: the inherent limitations of risk stratification in hypertrophic cardiomyopathy.
    Kohorst JJ; Bos JM; Hagler DJ; Ackerman MJ
    Congenit Heart Dis; 2014; 9(2):E51-7. PubMed ID: 23648018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Searching for triggers of sudden death in hypertrophic cardiomyopathy: chasing after the wind?
    Jayachandran JV
    Heart Rhythm; 2009 May; 6(5):603-4. PubMed ID: 19389646
    [No Abstract]   [Full Text] [Related]  

  • 12. Sudden death in hypertrophic cardiomyopathy.
    Watkins H
    N Engl J Med; 2000 Feb; 342(6):422-4. PubMed ID: 10666434
    [No Abstract]   [Full Text] [Related]  

  • 13. Sudden death in hypertrophic cardiomyopathy: risk stratification and prevention.
    Valgaeren G; Conraads V; Colpaert C; Rademakers F; Vrints C
    Acta Cardiol; 1998; 53(1):23-9. PubMed ID: 9638966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sudden death and hypertrophic cardiomyopathy: a review.
    Ly HQ; Greiss I; Talakic M; Guerra PG; Macle L; Thibault B; Dubuc M; Roy D
    Can J Cardiol; 2005 Apr; 21(5):441-8. PubMed ID: 15861263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sudden cardiac death risk in hypertrophic cardiomyopathy.
    Ommen SR; Gersh BJ
    Eur Heart J; 2009 Nov; 30(21):2558-9. PubMed ID: 19706724
    [No Abstract]   [Full Text] [Related]  

  • 16. Sudden cardiac death due to hypertrophic cardiomyopathy can be reduced by pre-participation cardiovascular screening in young athletes.
    Panhuyzen-Goedkoop NM; Verheugt FW
    Eur Heart J; 2006 Sep; 27(18):2152-3. PubMed ID: 16877480
    [No Abstract]   [Full Text] [Related]  

  • 17. [Sudden death in hypertrophic obstructive and non-obstructive cardiomyopathy: can it be prevented?].
    Grobéty M; Schlaepfer J; Kappenberger L; Fromer M
    Schweiz Med Wochenschr; 1997 Apr; 127(15):623-30. PubMed ID: 9198888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypertrophic cardiomyopathy: do sudden death prevention strategies in children differ between Europe and North America?
    Östman-Smith I; Rossano JW; Shaddy RE
    Curr Opin Cardiol; 2013 Mar; 28(2):130-8. PubMed ID: 23348710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ten common questions about hypertrophic cardiomyopathy...and misconceptions.
    Maron BJ
    Cardiol Rev; 2005; 13(2):59-60. PubMed ID: 15705254
    [No Abstract]   [Full Text] [Related]  

  • 20. Prophylactic implantable defibrillators for hypertrophic cardiomyopathy: disarray in the era of precision medicine.
    Grace A
    Circ Arrhythm Electrophysiol; 2015 Aug; 8(4):763-6. PubMed ID: 26286301
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.